Eurofins is a global leader in bioanalysis represented in 25 countries around the world, with sales that will exceed €450m in 2007. It floated on the Nouveau Marché in October 1997, and is today listed on Eurolist B. The stock is part of SBF250, Mid100, Mid&Small190, CAC Allshares, Next150 indices.

Eurofins, that was founded twenty years ago, is proud to be a €1 billion company today, operating in markets turned towards the benefit of human kind, helping in the research for ever more beneficial drugs.

Martine Charbonnier, Executive Director Listing NYSE Euronext congratulates Gilles Martin, CEO of Eurofins.